Atlas Trials

Evaluation of Loratadine for Prevention of Pegfilgrastim-Induced Pain

Clinical trial NCT01311336 · UNKNOWN

Trial details

NCT number
NCT01311336
Sponsor
University of Vermont
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pegfilgrastim-induced Back and Leg Pain
Start date
2011-05-01
Primary completion
2013-06-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.